Envelope domain III E324, E351, and E380 mutations lever adaptive evolution of DENV-1 genotype I
- PMID: 39230303
- PMCID: PMC11495034
- DOI: 10.1128/jvi.01183-24
Envelope domain III E324, E351, and E380 mutations lever adaptive evolution of DENV-1 genotype I
Abstract
Dengue virus (DENV) gains genetic mutations during continuous transmission and evolution, making the virus more adaptive and virulent. The clade of DENV-1 genotype I has expanded and become the predominant genotype in Asia and the Pacific areas, but the underlying mechanisms are unclear. A combined analysis of nonsynonymous mutations in domain III of the envelope protein and their biological effects on virus pathogenesis and transmission was evaluated. Phylogenetic analyses found three nonsynonymous mutations (V324I, V351L, and V380I) in domain III of the envelope protein, which emerged in 1970s-1990s and stably inherited and expanded in contemporary strains after 2000. We generated reverse-mutated viruses (I324V, L351V, and I380V) based on an infectious clone of an epidemic DENV-1 strain (NIID02-20), and the results suggested that the infectivity of the contemporary epidemic virus (wild type, WT) has increased compared to the reverse mutant viruses in mammalian hosts but not mosquito vectors. The WT virus showed a higher binding affinity to host cells and increased virion stability. In addition, weaker immunogenicity and higher resistance to neutralizing antibodies of the WT virus indicated a trend of immune escape. The data suggested that nonsynonymous mutations of the E protein (V324I, V351L, and V380I) promote infectivity and immune evasion of DENV-1 genotype I, which may facilitate its onward transmission on a global scale.
Importance: We provide evidence that minor sequence variation among dengue virus (DENV) strains can result in increased adaptability and virulence, impacting both the biology of the virus and the antiviral immune response. The genetic mutations of DENV-1 gained during continuous transmission and evolution will offer new clues for the design of novel vaccines against flaviviruses.
Keywords: adaptive evolution; dengue virus 1; envelope protein; mutation; reverse genetics.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Increasing Clinical Severity during a Dengue Virus Type 3 Cuban Epidemic: Deep Sequencing of Evolving Viral Populations.J Virol. 2016 Apr 14;90(9):4320-4333. doi: 10.1128/JVI.02647-15. Print 2016 May. J Virol. 2016. PMID: 26889031 Free PMC article.
-
Dengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeys.PLoS One. 2014 Jun 24;9(6):e100130. doi: 10.1371/journal.pone.0100130. eCollection 2014. PLoS One. 2014. PMID: 24959738 Free PMC article.
-
Genotype-specific neutralization and protection by antibodies against dengue virus type 3.J Virol. 2010 Oct;84(20):10630-43. doi: 10.1128/JVI.01190-10. Epub 2010 Aug 11. J Virol. 2010. PMID: 20702644 Free PMC article.
-
Phylogenetic analysis of partial pre-membrane and envelope sequences of dengue viruses circulating in India.Int J Infect Dis. 2019 Jul;84S:S44-S56. doi: 10.1016/j.ijid.2019.04.010. Epub 2019 Apr 17. Int J Infect Dis. 2019. PMID: 31002930
-
Evolution of dengue virus type 3 genotype III in Venezuela: diversification, rates and population dynamics.Virol J. 2010 Nov 18;7:329. doi: 10.1186/1743-422X-7-329. Virol J. 2010. PMID: 21087501 Free PMC article.
References
-
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504–507. doi:10.1038/nature12060 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- 2020YFC1200100/MOST | National Key Research and Development Program of China (NKPs)
- 2022B1111030002/The Guangdong Science and Technology Program
- BK20211310/JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- 81971917 and 32170142/MOST | National Natural Science Foundation of China (NSFC)
LinkOut - more resources
Full Text Sources
Medical